Genetic Technologies Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Genetic Technologies Limited's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 26% to $7,664,784. Profit margin reached -157%. Total operating expenses were $3,904,474.

Profit Margin

Genetic Technologies Limited (NASDAQ:GENE): Profit margin
2015 2.01M -8.81M -437.9%
2016 824.58K -8.45M -1025.84%
2017 518.50K -8.40M -1620.78%
2018 189.25K -5.46M -2887.06%
2019 25.44K -6.83M -26855.39%
2020 837.86K -6.29M -751.29%
2021 120.55K -7.20M -5979.01%
2022 6.79M -7.13M -104.95%
2023 10.34M -11.75M -113.56%
2024 7.66M -12.01M -156.78%

GENE Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
7.66M10.34M6.79M120.55K837.86K25.44K189.25K518.50K824.58K2.01M
Cost of revenue
3.76M4.33M321.22K361.02K101.43K276.26K300.08K492.41K743.06K1.32M
Gross profit
3.90M6.01M6.47M-240.47K736.43K-250.82K-110.83K26.08K81.52K685.25K
Operating exp.
Research and development
752.75K1.28M705.50K3.10M865.62K2.36M2.21M2.36M2.58M2.85M
Selling and marketing
2.60M2.94M1.88M1.11M279.31K576.07K1.06M2.72M3.18M4.50M
Total operating expenses
3.90M18.11M3.10M7.00M6.98M5.91M5.86M8.43M8.64M9.27M
Operating income
-6.53M-10.41M-4.29M-7.06M-5.93M-5.99M-5.97M-8.17M-8.45M-9.86M
Other income (expenses), net
-5.48M-1.49M-2.87M-14.04K-1.90M-427.51K527.04K-232.57K65.13K1.05M
Income before tax
-12.01M-11.90M-7.16M-7.07M-6.29M-6.42M-5.46M-8.40M-8.45M-8.81M
Income tax expense
0158.32K-32.12K130.32K-750K407.48K542.26K-253.15K-303.18K0
Net income
-12.01M-11.75M-7.13M-7.20M-6.29M-6.83M-5.46M-8.40M-8.45M-8.81M
Earnings per share
Basic EPS
-0.09-0.36-0.07-0.08-0.45-0.24-1.35-1.2-2.76-2.46
Diluted EPS
-0.09-0.36-0.07-0.08-0.45-0.24-1.35-1.2-2.76-2.46
Data sourceData sourceData sourceData sourceData sourceData source